Dynamic Technology Lab’s Passage Bio PASG Stock Holding History

Dynamic Technology Lab’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-889	Closed	-$177K	–	1398
2021 Q3	$177K	Buy	+889	New	+$212K	0.02%	925

Other funds holding PASG

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dynamic Technology Lab's PASG Position: Q4 2021 in Review

Dynamic Technology Lab sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 889 shares — an estimated $177K sold.

Dynamic Technology Lab first reported a position in PASG in Q3 2021 and held it in 1 quarter. The position peaked at $177K in Q3 2021. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

Dynamic Technology Lab reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
Dynamic Technology Lab sold 889 Passage Bio shares in Q4 2021, an estimated $177K.
Dynamic Technology Lab first reported a position in Passage Bio in Q3 2021 and held it in 1 quarter.
Dynamic Technology Lab's Passage Bio position peaked at $177K in Q3 2021.
99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on Dynamic Technology Lab's 13F filing for Q4 2021, filed 14 Feb 2022.